What does Avego Bioscience Capital invest in?
Avego Bioscience Capital invests most often at Series A and Series B (63% of the rounds on record).
Last cheque observed Jun 2026; 8 cheques on record.
Deploying nowNew fund $60M, Apr 2026Private equity
Follow Avego Bioscience Capital and see its new cheques in your feed.Start following
4 cheques in the last 12 months
Mostly Series A and Series B: 63% of its rounds
Led 1 rounds
Every round we can evidence, newest first8 appearances
4 rounds
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
We also hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The investors most often in the same rounds as Avego Bioscience Capital. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Avego Bioscience Capital put money into.
Avego Bioscience Capital invests most often at Series A and Series B (63% of the rounds on record).
8 investments on record, 4 of them in the last 12 months, and it led 1. The most recent was in Jun 2026.
Its most recent investments on record: Memento Medicines (Series A, Jun 2026), Alveus Therapeutics Inc. (Series A, Feb 2026) and Alveus Therapeutics (Series A, Jan 2026).
The median round it joins is $140M.
Sometimes: it led 1 of its 8 investments on record (13%).
Most of the companies it backs are in the United States (63%), the United Kingdom (25%) and Switzerland (13%).
Yes: it is actively investing, with 4 investments in the last 12 months.
Most often Sanofi (4 rounds together), Forbion Capital Partners (3 rounds together) and Novo Holdings (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it